Manina Medtech is developing Seedchrony, a medical device designed to determine whether the uterus is prepared for embryo implantation on the day of transfer. Seedchrony provides real-time assessment aimed at improving IVF success rates. The company intends to industrialise the device and complete clinical validation, efforts explicitly cited as the use for its latest financing. Manina Medtech previously completed a seed funding round and has now closed an additional, undisclosed financing round. Legal adviser RCD, led by Ramon Manyà on the transaction, has an ongoing advisory relationship with the company.

Total raised

$2M

Funding rounds

2

Latest round

Equity

Latest activity

Jan 2024